Canada markets closed

NLS Pharmaceutics Ltd. (NLSP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1339-0.0058 (-4.15%)
At close: 04:00PM EDT
0.1313 -0.00 (-1.94%)
After hours: 05:41PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.00M
Enterprise Value 5.00M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.84
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.33

Trading Information

Stock Price History

Beta (5Y Monthly) -0.84
52-Week Change 3-89.55%
S&P500 52-Week Change 323.10%
52 Week High 31.5300
52 Week Low 30.1130
50-Day Moving Average 30.2383
200-Day Moving Average 30.5573

Share Statistics

Avg Vol (3 month) 3607.92k
Avg Vol (10 day) 3203.61k
Shares Outstanding 543.32M
Implied Shares Outstanding 643.32M
Float 819.89M
% Held by Insiders 131.54%
% Held by Institutions 123.84%
Shares Short (Apr 15, 2024) 475.11k
Short Ratio (Apr 15, 2024) 40.05
Short % of Float (Apr 15, 2024) 40.23%
Short % of Shares Outstanding (Apr 15, 2024) 40.17%
Shares Short (prior month Mar 15, 2024) 435.24k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-414.25%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.33M
Net Income Avi to Common (ttm)-15.47M
Diluted EPS (ttm)-0.5000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.65M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.58
Book Value Per Share (mrq)-0.13

Cash Flow Statement

Operating Cash Flow (ttm)-13.51M
Levered Free Cash Flow (ttm)-7.95M